Total Payments
$13,383
2024 Payments
$7,560
Companies
9
Transactions
21
Medicare Patients
3,536
Medicare Billing
$823,507
Payment Breakdown by Category
Other$12,883 (96.3%)
Food & Beverage$388.77 (2.9%)
Education$111.19 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $12,883 | 2 | 96.3% |
| Food and Beverage | $388.77 | 12 | 2.9% |
| Education | $111.19 | 7 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AngioDynamics, Inc. | $12,883 | 2 | $0 (2024) |
| Genentech USA, Inc. | $279.00 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $61.70 | 3 | $0 (2023) |
| Amgen Inc. | $46.27 | 2 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $44.75 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $36.31 | 2 | $0 (2024) |
| Aurinia Pharma U.S., Inc. | $19.74 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,560 | 5 | AngioDynamics, Inc. ($7,500) |
| 2023 | $5,467 | 5 | AngioDynamics, Inc. ($5,383) |
| 2022 | $40.30 | 2 | AstraZeneca Pharmaceuticals LP ($20.56) |
| 2021 | $3.82 | 1 | Travere Therapeutics, Inc. ($3.82) |
| 2020 | $29.20 | 2 | Amgen Inc. ($25.38) |
| 2019 | $84.18 | 4 | Genentech USA, Inc. ($80.00) |
| 2018 | $99.00 | 1 | Genentech USA, Inc. ($99.00) |
| 2017 | $100.00 | 1 | Genentech USA, Inc. ($100.00) |
All Payment Transactions
21 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $7,500.00 | General |
| Category: ET | ||||||
| 05/16/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Inflammation/Rare Disease | ||||||
| 05/07/2024 | Travere Therapeutics, Inc. | — | Education | In-kind items and services | $0.37 | General |
| 03/12/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $15.02 | General |
| 01/24/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: NEPHROLOGY | ||||||
| 12/31/2023 | AngioDynamics, Inc. | Auryon Laser System 100-120 Vac (Device) | Long term medical supply or device loan | In-kind items and services | $5,383.33 | General |
| Category: ET | ||||||
| 12/12/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2023 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $21.29 | General |
| 07/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/24/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: NEPHROLOGY | ||||||
| 10/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/03/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/02/2021 | Travere Therapeutics, Inc. | Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 06/19/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $25.38 | General |
| Category: Nephrology | ||||||
| 05/08/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $3.82 | General |
| Category: Kidney Stones | ||||||
| 10/24/2019 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $80.00 | General |
| Category: BioOncology/Immunology | ||||||
| 05/23/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $2.33 | General |
| Category: Kidney Stones | ||||||
| 05/23/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $1.31 | General |
| Category: Kidney Stones | ||||||
| 05/23/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Education | In-kind items and services | $0.54 | General |
| Category: Kidney Stones | ||||||
| 08/09/2018 | Genentech USA, Inc. | Rituxan (Biological), Actemra | Education | In-kind items and services | $99.00 | General |
| Category: BioOncology/Immunology | ||||||
| 06/06/2017 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 655 | 1,350 | $725,105 | $150,655 |
| 2022 | 16 | 757 | 1,322 | $539,651 | $168,635 |
| 2021 | 15 | 992 | 1,784 | $341,242 | $252,978 |
| 2020 | 18 | 1,132 | 2,738 | $343,201 | $251,239 |
Total Patients
3,536
Total Services
7,194
Medicare Billing
$823,507
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 55 | 197 | $236,006 | $54,180 | 23.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 210 | 347 | $152,333 | $21,149 | 13.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 32 | 84 | $83,496 | $19,591 | 23.5% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 12 | 45 | $44,640 | $10,419 | 23.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 88 | 156 | $36,972 | $9,313 | 25.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 56 | 56 | $41,944 | $8,652 | 20.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 37 | 47 | $34,216 | $7,417 | 21.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 36 | 52 | $17,732 | $4,678 | 26.4% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 20 | 126 | $21,168 | $4,264 | 20.1% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 16 | 102 | $21,318 | $3,600 | 16.9% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 33 | 49 | $11,858 | $2,577 | 21.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $10,776 | $2,375 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $6,798 | $1,235 | 18.2% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 16 | 43 | $5,848 | $1,207 | 20.6% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 58 | 287 | $228,365 | $77,821 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 205 | 323 | $96,676 | $22,122 | 22.9% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 23 | 60 | $37,349 | $13,273 | 35.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 29 | 49 | $29,022 | $11,133 | 38.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 55 | 55 | $26,229 | $7,943 | 30.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 60 | 89 | $23,043 | $6,757 | 29.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 28 | 36 | $20,543 | $5,952 | 29.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 68 | 108 | $14,871 | $5,669 | 38.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 35 | $16,583 | $4,968 | 30.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 84 | 104 | $16,770 | $4,409 | 26.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 43 | 72 | $11,610 | $3,786 | 32.6% |
About Dr. Ramesh Marahatta, MD
Dr. Ramesh Marahatta, MD is a Nephrology healthcare provider based in Springfield, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2009. The National Provider Identifier (NPI) number assigned to this provider is 1679700280.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ramesh Marahatta, MD has received a total of $13,383 in payments from pharmaceutical and medical device companies, with $7,560 received in 2024. These payments were reported across 21 transactions from 9 companies. The most common payment nature is "Long term medical supply or device loan" ($12,883).
As a Medicare-enrolled provider, Marahatta has provided services to 3,536 Medicare beneficiaries, totaling 7,194 services with total Medicare billing of $823,507. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Springfield, OR
- Active Since 06/22/2009
- Last Updated 12/22/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1679700280
Products in Payments
- Auryon Laser System 100-120 Vac (Device) $12,883
- Rituxan (Biological) $279.00
- FARXIGA (Drug) $61.70
- JYNARQUE (Drug) $44.75
- Parsabiv (Drug) $25.38
- KRYSTEXXA (Biological) $20.89
- LUPKYNIS (Drug) $19.74
- (815) Thiola (Drug) $8.00
- Thiola (Drug) $3.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Springfield
Dr. Michael Germain, Md, MD
Nephrology — Payments: $526,036
Nephrology $526,036
Merry Downer, M.d, M.D
Nephrology — Payments: $121,311
Nephrology $121,311
Dr. Jonathan Slater, M.d, M.D
Nephrology — Payments: $87,645
Nephrology $87,645
Sanju Varghese, Md, MD
Nephrology — Payments: $54,504
Nephrology $54,504
Thomas Ebert, M.d, M.D
Nephrology — Payments: $9,270
Nephrology $9,270
Dr. Barbara Greco, Md, MD
Nephrology — Payments: $7,756
Nephrology $7,756